| Adderall IRmixed amphetamine salts | Stimulant (amphetamine) | 4–6 h | $20–40/mo | Appetite loss, insomnia, dry mouth, anxiety | Short-acting; often dosed twice daily. |
| Adderall XRmixed amphetamine salts ER | Stimulant (amphetamine) | 8–12 h | $25–60/mo | Appetite loss, insomnia, dry mouth | Extended release; once-daily morning dose. |
| Vyvanselisdexamfetamine | Stimulant (amphetamine) | 10–14 h | $60–120/mo | Appetite loss, insomnia, irritability | Prodrug — smoother onset, lower abuse potential. Generic since 2023. |
| Ritalin IRmethylphenidate | Stimulant (methylphenidate) | 3–5 h | $15–30/mo | Appetite loss, insomnia, stomach ache | Shortest-acting option; fast on, fast off. |
| Concertamethylphenidate ER | Stimulant (methylphenidate) | 10–12 h | $30–70/mo | Appetite loss, insomnia, headache | OROS pump delivery — steady release across the day. |
| Focalin XRdexmethylphenidate ER | Stimulant (methylphenidate) | 8–12 h | $30–70/mo | Appetite loss, anxiety, dry mouth | Refined isomer of methylphenidate; some tolerate it better. |
| Stratteraatomoxetine | Non-stimulant | 24 h | $25–60/mo | Nausea, fatigue, decreased appetite | Not a controlled substance. Takes 2–6 weeks for full effect. |
| Qelbreeviloxazine ER | Non-stimulant | 24 h | $300+/mo (no generic) | Sleepiness, nausea, decreased appetite | Newest non-stimulant; no generic yet, so pricey. |
| Intunivguanfacine ER | Non-stimulant | 24 h | $15–35/mo | Drowsiness, low blood pressure, dizziness | Often added to a stimulant; helps with emotional regulation. |